OSR Health (OSRHW) Minority Interest (2025 - 2026)
OSR Health (OSRHW) posted Minority Interest of $23.5 million for Q1 2026, down 52.37% sequentially from $49.4 million in Q4 2025, and down 58.37% YoY from $56.5 million in Q1 2025.
OSR Health (OSRHW) Minority Interest (2025 - 2026) Analysis & Trends
OSR Health has reported Minority Interest for 2 years, with the latest figure at $23.5 million in Q1 2026.
- Quarterly Minority Interest fell 58.37% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (down 58.37% YoY) and the FY2025 annual result came in at $49.4 million, changed N/A from the prior year.
- Minority Interest eased to $23.5 million in Q1 2026 per OSRHW's latest filing, from $49.4 million in the prior quarter.
- Over five years, Minority Interest peaked at $56.5 million in Q1 2025 and troughed at $23.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.53 Mn |
| Dec 31, 2025 | 49.40 Mn |
| Sep 30, 2025 | 52.21 Mn |
| Jun 30, 2025 | 55.45 Mn |
| Mar 31, 2025 | 56.52 Mn |